CN107737283A - 一种治疗流泪症的中药组合物及其制备方法 - Google Patents
一种治疗流泪症的中药组合物及其制备方法 Download PDFInfo
- Publication number
- CN107737283A CN107737283A CN201711274803.6A CN201711274803A CN107737283A CN 107737283 A CN107737283 A CN 107737283A CN 201711274803 A CN201711274803 A CN 201711274803A CN 107737283 A CN107737283 A CN 107737283A
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- disease
- medicine composition
- tears
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 201000010099 disease Diseases 0.000 title claims abstract description 39
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title claims abstract description 39
- 239000003814 drug Substances 0.000 title claims abstract description 35
- 239000000203 mixture Substances 0.000 title claims abstract description 31
- 238000002360 preparation method Methods 0.000 title claims abstract description 12
- 239000000463 material Substances 0.000 claims abstract description 41
- 239000008280 blood Substances 0.000 claims abstract description 32
- 210000004369 blood Anatomy 0.000 claims abstract description 32
- 244000025254 Cannabis sativa Species 0.000 claims abstract description 20
- 241000143476 Bidens Species 0.000 claims abstract description 17
- 235000010662 Bidens pilosa Nutrition 0.000 claims abstract description 17
- 241000345998 Calamus manan Species 0.000 claims abstract description 17
- 241000219793 Trifolium Species 0.000 claims abstract description 17
- 235000012950 rattan cane Nutrition 0.000 claims abstract description 17
- 235000006793 Artemisia stelleriana Nutrition 0.000 claims abstract description 16
- 244000252230 Artemisia stelleriana Species 0.000 claims abstract description 16
- 241001123263 Zostera Species 0.000 claims abstract description 16
- 235000006413 coastal sagewort Nutrition 0.000 claims abstract description 16
- 244000037364 Cinnamomum aromaticum Species 0.000 claims abstract description 15
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 claims abstract description 15
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 52
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 25
- 238000000605 extraction Methods 0.000 claims description 19
- 239000000706 filtrate Substances 0.000 claims description 19
- 238000001914 filtration Methods 0.000 claims description 16
- 238000000034 method Methods 0.000 claims description 11
- 239000006071 cream Substances 0.000 claims description 9
- 238000002156 mixing Methods 0.000 claims description 6
- 238000010992 reflux Methods 0.000 claims description 5
- 238000003809 water extraction Methods 0.000 claims description 2
- 241000522169 Lespedeza Species 0.000 abstract description 12
- 210000004185 liver Anatomy 0.000 description 19
- 235000013339 cereals Nutrition 0.000 description 13
- 239000000796 flavoring agent Substances 0.000 description 12
- 235000019634 flavors Nutrition 0.000 description 12
- 239000007788 liquid Substances 0.000 description 11
- 208000002193 Pain Diseases 0.000 description 8
- 239000006188 syrup Substances 0.000 description 8
- 235000020357 syrup Nutrition 0.000 description 8
- 239000002775 capsule Substances 0.000 description 7
- 229920002472 Starch Polymers 0.000 description 6
- 210000003734 kidney Anatomy 0.000 description 6
- 238000004519 manufacturing process Methods 0.000 description 6
- 239000008107 starch Substances 0.000 description 6
- 235000019698 starch Nutrition 0.000 description 6
- 206010017553 Furuncle Diseases 0.000 description 5
- 230000017531 blood circulation Effects 0.000 description 5
- 208000001848 dysentery Diseases 0.000 description 5
- 231100000614 poison Toxicity 0.000 description 5
- 230000003213 activating effect Effects 0.000 description 4
- 235000009508 confectionery Nutrition 0.000 description 4
- 230000007812 deficiency Effects 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 4
- 230000001737 promoting effect Effects 0.000 description 4
- 230000008961 swelling Effects 0.000 description 4
- 206010000087 Abdominal pain upper Diseases 0.000 description 3
- 229920001353 Dextrin Polymers 0.000 description 3
- 239000004375 Dextrin Substances 0.000 description 3
- 206010023644 Lacrimation increased Diseases 0.000 description 3
- 229930006000 Sucrose Natural products 0.000 description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 3
- 239000000853 adhesive Substances 0.000 description 3
- 230000001070 adhesive effect Effects 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 235000019425 dextrin Nutrition 0.000 description 3
- 239000003085 diluting agent Substances 0.000 description 3
- FPAFDBFIGPHWGO-UHFFFAOYSA-N dioxosilane;oxomagnesium;hydrate Chemical compound O.[Mg]=O.[Mg]=O.[Mg]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O FPAFDBFIGPHWGO-UHFFFAOYSA-N 0.000 description 3
- 239000007884 disintegrant Substances 0.000 description 3
- 208000002173 dizziness Diseases 0.000 description 3
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 3
- 230000004438 eyesight Effects 0.000 description 3
- 238000011049 filling Methods 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 208000014674 injury Diseases 0.000 description 3
- 230000004317 lacrimation Effects 0.000 description 3
- 239000000314 lubricant Substances 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 239000002574 poison Substances 0.000 description 3
- 239000003755 preservative agent Substances 0.000 description 3
- 230000002335 preservative effect Effects 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 235000021251 pulses Nutrition 0.000 description 3
- 239000004334 sorbic acid Substances 0.000 description 3
- 235000010199 sorbic acid Nutrition 0.000 description 3
- 229940075582 sorbic acid Drugs 0.000 description 3
- 210000000952 spleen Anatomy 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 239000005720 sucrose Substances 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- 230000008736 traumatic injury Effects 0.000 description 3
- 230000010415 tropism Effects 0.000 description 3
- 239000000080 wetting agent Substances 0.000 description 3
- 206010003011 Appendicitis Diseases 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- 201000004624 Dermatitis Diseases 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 208000005577 Gastroenteritis Diseases 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- 208000015817 Infant Nutrition disease Diseases 0.000 description 2
- 206010023126 Jaundice Diseases 0.000 description 2
- 239000002202 Polyethylene glycol Chemical class 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- 208000004078 Snake Bites Diseases 0.000 description 2
- 241001072888 Teucrium Species 0.000 description 2
- 206010052428 Wound Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 210000001015 abdomen Anatomy 0.000 description 2
- 208000010668 atopic eczema Diseases 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 239000001913 cellulose Chemical class 0.000 description 2
- 235000010980 cellulose Nutrition 0.000 description 2
- 229920002678 cellulose Chemical class 0.000 description 2
- 239000002131 composite material Substances 0.000 description 2
- 239000006184 cosolvent Substances 0.000 description 2
- 239000003937 drug carrier Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 235000019441 ethanol Nutrition 0.000 description 2
- 125000004494 ethyl ester group Chemical group 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 238000005469 granulation Methods 0.000 description 2
- 230000003179 granulation Effects 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 208000006454 hepatitis Diseases 0.000 description 2
- 241000411851 herbal medicine Species 0.000 description 2
- 235000021374 legumes Nutrition 0.000 description 2
- 201000005630 leukorrhea Diseases 0.000 description 2
- -1 liquid paraffin Substances 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 235000019359 magnesium stearate Nutrition 0.000 description 2
- 208000004396 mastitis Diseases 0.000 description 2
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 2
- 229920001223 polyethylene glycol Chemical class 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 201000004896 stenosis of lacrimal passage Diseases 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 206010046901 vaginal discharge Diseases 0.000 description 2
- 235000020985 whole grains Nutrition 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010000077 Abdominal mass Diseases 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- 241000282817 Bovidae Species 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 235000006719 Cassia obtusifolia Nutrition 0.000 description 1
- 244000277285 Cassia obtusifolia Species 0.000 description 1
- 244000201986 Cassia tora Species 0.000 description 1
- 235000008495 Chrysanthemum leucanthemum Nutrition 0.000 description 1
- 244000192528 Chrysanthemum parthenium Species 0.000 description 1
- 235000000604 Chrysanthemum parthenium Nutrition 0.000 description 1
- 208000034656 Contusions Diseases 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 208000008967 Enuresis Diseases 0.000 description 1
- 241000909851 Epiphora Species 0.000 description 1
- 201000000297 Erysipelas Diseases 0.000 description 1
- 108010010803 Gelatin Chemical class 0.000 description 1
- 206010018612 Gonorrhoea Diseases 0.000 description 1
- 208000000616 Hemoptysis Diseases 0.000 description 1
- 208000004044 Hypesthesia Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 241001166994 Kummerowia striata Species 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 244000297531 Lespedeza cuneata Species 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 208000037093 Menstruation Disturbances Diseases 0.000 description 1
- 206010027339 Menstruation irregular Diseases 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- 208000007443 Neurasthenia Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 201000005702 Pertussis Diseases 0.000 description 1
- 206010034960 Photophobia Diseases 0.000 description 1
- 241000722363 Piper Species 0.000 description 1
- 241000671769 Piper puberulum Species 0.000 description 1
- 241001529246 Platymiscium Species 0.000 description 1
- 241000219050 Polygonaceae Species 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- QOSMNYMQXIVWKY-UHFFFAOYSA-N Propyl levulinate Chemical compound CCCOC(=O)CCC(C)=O QOSMNYMQXIVWKY-UHFFFAOYSA-N 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 241000593989 Scardinius erythrophthalmus Species 0.000 description 1
- 240000006079 Schisandra chinensis Species 0.000 description 1
- 235000008422 Schisandra chinensis Nutrition 0.000 description 1
- 241000561693 Schisandra henryi Species 0.000 description 1
- 241000780602 Senecio Species 0.000 description 1
- 241001146210 Senecio scandens Species 0.000 description 1
- 240000003705 Senecio vulgaris Species 0.000 description 1
- 241000270295 Serpentes Species 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 241001180441 Sparganium stoloniferum Species 0.000 description 1
- 241001517403 Spiranthes Species 0.000 description 1
- 244000174897 Spiranthes australis Species 0.000 description 1
- 241000233945 Typhaceae Species 0.000 description 1
- 206010047513 Vision blurred Diseases 0.000 description 1
- 244000147839 Zornia reticulata Species 0.000 description 1
- 206010000269 abscess Diseases 0.000 description 1
- LPQOADBMXVRBNX-UHFFFAOYSA-N ac1ldcw0 Chemical compound Cl.C1CN(C)CCN1C1=C(F)C=C2C(=O)C(C(O)=O)=CN3CCSC1=C32 LPQOADBMXVRBNX-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 208000012873 acute gastroenteritis Diseases 0.000 description 1
- OBETXYAYXDNJHR-UHFFFAOYSA-N alpha-ethylcaproic acid Natural products CCCCC(CC)C(O)=O OBETXYAYXDNJHR-UHFFFAOYSA-N 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- VQLYBLABXAHUDN-UHFFFAOYSA-N bis(4-fluorophenyl)-methyl-(1,2,4-triazol-1-ylmethyl)silane;methyl n-(1h-benzimidazol-2-yl)carbamate Chemical compound C1=CC=C2NC(NC(=O)OC)=NC2=C1.C=1C=C(F)C=CC=1[Si](C=1C=CC(F)=CC=1)(C)CN1C=NC=N1 VQLYBLABXAHUDN-UHFFFAOYSA-N 0.000 description 1
- 208000034526 bruise Diseases 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 230000009194 climbing Effects 0.000 description 1
- 235000008504 concentrate Nutrition 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 208000028659 discharge Diseases 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000000744 eyelid Anatomy 0.000 description 1
- 235000008384 feverfew Nutrition 0.000 description 1
- 210000004904 fingernail bed Anatomy 0.000 description 1
- 238000011010 flushing procedure Methods 0.000 description 1
- 208000003512 furunculosis Diseases 0.000 description 1
- 239000008273 gelatin Chemical class 0.000 description 1
- 229920000159 gelatin Chemical class 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 208000034783 hypoesthesia Diseases 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 230000002262 irrigation Effects 0.000 description 1
- 238000003973 irrigation Methods 0.000 description 1
- 206010023332 keratitis Diseases 0.000 description 1
- 208000016747 lacrimal apparatus disease Diseases 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 208000018191 liver inflammation Diseases 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 150000004702 methyl esters Chemical class 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 201000002266 mite infestation Diseases 0.000 description 1
- 230000000116 mitigating effect Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 235000013809 polyvinylpolypyrrolidone Nutrition 0.000 description 1
- 229920000523 polyvinylpolypyrrolidone Polymers 0.000 description 1
- ULWHHBHJGPPBCO-UHFFFAOYSA-N propane-1,1-diol Chemical class CCC(O)O ULWHHBHJGPPBCO-UHFFFAOYSA-N 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000013049 sediment Substances 0.000 description 1
- 208000013220 shortness of breath Diseases 0.000 description 1
- 238000007873 sieving Methods 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 150000005846 sugar alcohols Chemical class 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 201000004647 tinea pedis Diseases 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 208000019206 urinary tract infection Diseases 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 231100000611 venom Toxicity 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/704—Polygonum, e.g. knotweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/32—Bones; Osteocytes; Osteoblasts; Tendons; Tenocytes; Teeth; Odontoblasts; Cartilage; Chondrocytes; Synovial membrane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/482—Cassia, e.g. golden shower tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/57—Magnoliaceae (Magnolia family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/67—Piperaceae (Pepper family), e.g. Jamaican pepper or kava
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/79—Schisandraceae (Schisandra family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/898—Orchidaceae (Orchid family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/902—Sparganiaceae (Bur-reed family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Biotechnology (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Biomedical Technology (AREA)
- Cell Biology (AREA)
- Developmental Biology & Embryology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Zoology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明涉及一种治疗流泪症的中药组合物及其制备方法。该中药是由扛板归、鸡眼草、山羊角、丁癸草、鬼针草、九里明、夜关门、盘龙参、血藤、皱面苦草、决明子、毛蒌、三棱等中药原料制备而成的。本发明还提供了这种中药组合物的制备方法。本发明提供的中药组合物主要用于治疗流泪症。
Description
技术领域
本发明涉及中药领域,具体涉及一种治疗流泪症的中药组合物及其制备方法。
背景技术
“流泪症”相当于西医的“泪溢”,是指泪液不能从泪道正常排出而溢出眼睑外的疾病,以间歇性或经常性流泪,泪液清晰为主要临床特征。流泪症又可分为功能性流泪和器质性流泪,功能性流泪症患者,泪道冲洗无阻力,液体顺利进入咽部;器质性流泪症患者,冲洗泪道发现泪道狭窄或阻塞,冲洗液部分或全部从泪小点反流。
对于功能性流泪症患者和部分器质性流泪症患者(即泪道狭窄),中医治疗有很好的疗效。中医认为流泪症的病因病机为肝血不足,泪窍不密,风邪外袭而致泪出;脾气亏虚,生化乏源,气血不足,不能收摄泪液而致泪出;泪为肝之液,肝肾同源,肝肾两虚,不能约束其液而流泪。其辨证论治为血虚夹风证,治法为补血养肝,祛风散邪;气血不足证,治法为益气养血,收摄止泪;肝肾两虚证,治法为补益肝肾,固摄止泪。
发明内容
本发明的目的是提供一种治疗流泪症的中药组合物;
本发明的另一目的是提供一种治疗流泪症的中药组合物的制备方法。
本发明的目的是通过下列的技术方案实现的:
本发明所述的治疗流泪症的中药组合物,是由如下重量份的中药原料制备而成的:
扛板归10-30份、山羊角20-40份、丁癸草10-30份、鸡眼草5-20份、鬼针草10-30份、夜关门10-30份、盘龙参20-40份、九里明5-20份、血藤10-30份、皱面苦草5-20份、决明子10-30份、毛蒌20-40份、三棱10-30份。
优选地,是由如下重量份的中药原料制备而成的:
扛板归15-25份、山羊角25-35份、丁癸草15-25份、鸡眼草10-15份、鬼针草15-25份、夜关门15-25份、盘龙参25-35份、九里明10-15份、血藤15-25份、皱面苦草10-15份、决明子15-25份、毛蒌25-35份、三棱15-25份。
以下是本发明中药制剂的药材来源:
山羊角,为牛科动物青羊的角。【性味】味咸,性寒。【归经】心,肝经。【功能主治】清热,镇惊,散瘀止痛。主小儿发热惊痫、头痛、产后腹痛、痛经。
扛板归,为蓼科植物扛板归的全草。【性味】酸苦,平。【功能主治】利水消肿,清热,活血,解毒。治水肿,黄疸,泄泻,疟疾,痢疾,百日咳,淋浊,丹毒,瘰疬,湿疹,疥癣。
丁癸草,为豆科丁癸草属植物丁癸草 Zornia diphylla (L.) Pers.,以全草入药。【性味】甘、淡、凉。【功能主治】清热解毒,凉血解毒。用于感冒,咽喉炎,急性黄疸型肝炎,急性胃肠炎,急性阑尾炎,小儿疳积,急性乳腺炎,眼角膜炎;外用治跌打损伤,痈疖肿毒,毒蛇咬伤。
鸡眼草,为豆科鸡眼草属植物鸡眼草Kummerowia striata (Thunb.)Schindl.,以全草入药。【性味】甘、淡,微寒。【功能主治】清热解毒,活血,利湿止泻。用于胃肠炎,痢疾,肝炎,夜盲症,泌尿系感染,跌打损伤,疔疮疖肿。
鬼针草,为菊科植物鬼针草的全草。【性味】味苦;性微寒。【功能主治】清热解毒;祛风除湿;活血消肿。主咽喉;肿痛;泄泻;痢疾;黄疸;肠痈;疔疮肿毒;蛇早咬伤;风湿痹痛;跌打损伤。
夜关门,为豆科植物截叶铁扫帚的全草或带根全草。【性味】苦辛,凉。【功能主治】补肝肾,益肺阴,散瘀消肿。治遗精,遗尿,白浊,白带,哮喘,胃痛,劳伤,小儿疳积,泻痢,跌打损伤,视力减退,目赤,乳痈。
盘龙参,兰科绶草属植物绶草Spiranthes australis (R. Brown.)Lindl.,以根、全草入药。【性味】甘、淡,平。【功能主治】滋阴益气,凉血解毒。用于病后体虚,神经衰弱,肺结核咯血,咽喉肿痛,小儿夏季热,糖尿病,白带;外用治毒蛇咬伤。
九里明,为菊科千里光属植物千里光Senecio scandens Buch.-Ham.,以全草入药。【性味】苦,辛,凉。有小毒。【功能主治】清热解毒,凉血消肿,清肝明目。用于风火赤眼,疮疖肿毒,皮肤湿疹及痢疾腹痛等病症。
血藤,为木兰科植物翼梗五味子或华中五味子的藤茎或根。【性味】辛酸,温。【功能主治】养血消瘀,理气化湿。治痨伤吐血,肢节酸疼,心胃气痛,脚气痿痹,月经不调,跌打损伤。
皱面苦草,唇形科石蚕属植物山藿香的全草。味苦微辛,性寒,无毒。内服凉血清热、去积散结。外用消炎退肿。
决明子,为豆科植物决明Cassia obtusifolia L. 或小决明Cassia tora L. 的干燥成熟种子。【性味】甘、苦、咸,微寒。【归经】归肝、大肠经。【功能主治】清热明目,润肠通便。用于目赤涩痛,羞明多泪,头痛眩晕,目暗不明,大便秘结。
毛蒌,胡椒科胡椒属植物毛蒟Piper puberulum (Benth.) Maxim.,以全株入药。【性味】辛,温。【功能主治】祛风活血,行气止痛。用于风湿性腰腿痛,跌打损伤,胃腹疼痛,产后风痛。
三棱,为黑三棱科植物黑三棱Sparganium stoloniferum Buch.-Ham.的干燥块茎。【性味】辛、苦,平。【归经】归肝、脾经。【功能主治】破血行气,消积止痛。用于症瘕痞块,瘀血经闭,食积胀痛。
本发明的另一方面是提供了本发明中药组合物的活性成分的制备方法,该方法是采用水提或40-80%体积百分浓度的乙醇提取制备而成。具体制备方法如下:
方案一:取全部药材,混合后加水提取2-3次,每次加水量相当于药材总重量的6-12倍,每次提取时间为1-3小时,合并提取液,滤过,滤液浓缩至70-80℃时相对密度为1.15-1.20的清膏,即得活性成分。
方案二:取全部药材,混合后用40-80%乙醇回流提取2-3次,每次乙醇用量为药材总量的4-10倍,提取时间为1-4小时,合并提取液,过滤,滤液浓缩至70-80℃时相对密度为1.15-1.20的清膏,即得活性成分。
方案三:取全部药材,混合后加水提取2-3次,每次加水量相当于药材总重量的6-12倍,每次提取时间为1-3小时,合并提取液,滤过,滤液浓缩至70-80℃时相对密度为1.15-1.20的清膏,加入乙醇,使含醇量为40-70%,静置12-24小时,滤过,滤液浓缩至70-80℃时相对密度为1.10-1.25的浸膏,即得活性成分。
本发明所述的治疗流泪症的中药组合物,还可以与医药学上可接受的载体配合,制成各种口服制剂,如丸剂、片剂、胶囊剂、口服液、糖浆剂、合剂等。
本发明的药学上可接受的载体包括但不限于以下:
口服制剂:
稀释剂:淀粉、糖粉、乳糖、糊精、微晶纤维素、无机盐、糖醇类等。
润湿剂与粘合剂:纯化水、乙醇、明胶、聚乙二醇、纤维素衍生物等。
崩解剂:淀粉、羧甲基淀粉钠、纤维素衍生物、交联聚维酮等。
润滑剂:硬脂酸镁、微粉硅胶、滑石粉、聚乙二醇等。
助溶剂:水、乙醇、甘油、丙二醇、液状石蜡、植物油等。
矫味剂:蔗糖、单糖、芳香剂等。
防腐剂:苯甲酸、山梨酸、甲酯、乙酯、丙酯等。
方法1:片剂
取方案一至方案三所得活性成分之一,加入片剂常用辅料,按常规生产方法制备得本发明片剂。
上述片剂常用辅料包括稀释剂、润湿剂、粘合剂、崩解剂、润滑剂之一或全部。
方法2:胶囊剂
取方案一至方案三所得活性成分之一,加入胶囊剂常用辅料,按常规生产方法制备得本发明胶囊剂。
上述胶囊剂常用辅料包括稀释剂、润湿剂、粘合剂、崩解剂、润滑剂之一或全部。
方法3:糖浆剂
取方案一至方案三所得活性成分之一,加入糖浆剂常用辅料,按常规生产方法制备得本发明糖浆剂。
上述糖浆剂常用辅料包括矫味剂、防腐剂、助溶剂之一或全部。
方法4:合剂
取方案一至方案三所得活性成分之一,加入合剂常用辅料,按常规生产方法制备得本发明合剂。
上述合剂常用辅料包括矫味剂、防腐剂之一或全部。
方法5:口服液
取方案一至方案三所得活性成分之一,溶解后净化、浓缩,加入口服液常用辅料,按常规生产方法制备得本发明口服液。
本申请组方经申请人多年临床经验化方而成。经申请人多年临床经验化方而成,以山羊角、血藤、三棱化肝经淤血,盘龙参、夜关门补肝肾、益气滋阴,使脾气升举;再以扛板归、鸡眼草、鬼针草、毛蒌活血解毒;辅以丁癸草、九里明、皱面苦草清肝经之热、凉血;决明子清肝明目。全方各药材相互配合,共奏化瘀养肝,通经活络,升举脾阳之功,对流泪症特别是肝经淤血所致的流泪症。
本发明提供的一种治疗流泪症的中药组合物具有以下优点:
1、本发明提供的组合物制剂安全有效,全方相互配合,共奏化瘀养肝,通经活络,升举脾阳之功,对流泪症特别是肝经淤血所致的流泪症。
2、经临床试验证明,用本发明对流泪症患者治疗后,有效率达97.44%,表明本发明能有效治疗流泪症。
3、本发明提供的中药组合物制剂,配方科学合理,工艺简单,口感好,成本低。
具体实施方式
下面通过实施例进一步说明本发明。应该理解的是,本发明的实施例是用于说明本发明而不是对本发明的限制。根据本发明的实质对本发明进行的简单改进都属于本发明要求保护的范围。除非另有说明,本发明中的乙醇量的百分数是体积百分数,v/v表示溶液的体积比。
实施例1 片剂
称取扛板归10g、山羊角20g、丁癸草10g、鸡眼草5g、鬼针草10g、夜关门10g、盘龙参20g、九里明5g、血藤10g、皱面苦草5g、决明子10g、毛蒌20g、三棱10g。加水提取3次,三次加水量分别为药材总重量的12倍、8倍、6倍,三次提取时间分别为3小时、2小时、1小时,合并提取液,滤过,滤液浓缩至70℃时相对密度为1.25的清膏,加入辅料淀粉、乙醇、滑石粉,制得片剂。
实施例2 颗粒剂
称取扛板归30g、山羊角40g、丁癸草30g、鸡眼草20g、鬼针草30g、夜关门30g、盘龙参40g、九里明20g、血藤30g、皱面苦草20g、决明子30g、毛蒌40g、三棱30g。用乙醇回流提取2次,每次乙醇浓度分别为80%、60%,每次乙醇用量分别为药材总量的10倍、8倍,提取时间分别为4小时、3小时,合并提取液,过滤,滤液浓缩至80℃时相对密度为1.10的浸膏,加入淀粉、糊精,制粒、干燥、整粒即得。
实施例3 糖浆剂
称取扛板归15g、山羊角25g、丁癸草15g、鸡眼草10g、鬼针草15g、夜关门15g、盘龙参25g、九里明10g、血藤15g、皱面苦草10g、决明子15g、毛蒌25g、三棱15g。加水提取2次,每次加水量分别相当于药材总重量的12倍、10倍,每次提取时间分别为3小时、2小时,合并提取液,滤过,滤液浓缩至80℃下相对密度为1.05的清膏,加入乙醇,使含醇量为70%,静置12小时,滤过,滤液浓缩至70℃时相对密度为1.25的浸膏,在浸膏中加入糖浆剂辅料蔗糖、山梨酸、水搅拌均匀,制得糖浆剂。
实施例4 胶囊剂
称取扛板归25g、山羊角35g、丁癸草25g、鸡眼草15g、鬼针草25g、夜关门25g、盘龙参35g、九里明15g、血藤25g、皱面苦草15g、决明子25g、毛蒌35g、三棱25g。用40%乙醇回流提取3次,每次乙醇用量分别为药材总量的10倍、8倍、4倍,提取时间分别3小时、2小时、1小时,合并提取液,过滤,滤液浓缩60℃时相对密度为1.25的浸膏,在浸膏中加入辅料淀粉、乙醇、糊精、硬脂酸镁,按常规方法制成胶囊剂。
实施例5 颗粒剂
称取扛板归20g、山羊角30g、丁癸草20g、鸡眼草12g、鬼针草20g、夜关门20g、盘龙参30g、九里明12g、血藤20g、皱面苦草12g、决明子20g、毛蒌30g、三棱20g。加水提取2次,两次加水量分别为药材总重量的10倍、8倍,两次提取时间分别为2小时、1小时,合并提取液,滤过,滤液浓缩至80℃时相对密度为1.10的浸膏。加入淀粉、糊精,制粒、干燥、整粒即得。
实施例6 片剂
称取扛板归12g、山羊角23g、丁癸草12g、鸡眼草8g、鬼针草12g、夜关门12g、盘龙参23g、九里明8g、血藤12g、皱面苦草8g、决明子12g、毛蒌23g、三棱12g。加水提取3次,三次加水量分别相当于药材总重量的12倍、8倍、6倍,每次提取时间分别3小时、2小时、1小时,合并提取液,滤过,滤液浓缩至70℃时相对密度为1.20的清膏,加入乙醇,使含醇量为40%,静置24小时,滤过,滤液浓缩至滤液浓缩至70℃时相对密度为1.10的浸膏,加入辅料淀粉、乙醇、滑石粉,制得片剂。
实施例7 合剂
称取扛板归18g、山羊角28g、丁癸草18g、鸡眼草11g、鬼针草18g、夜关门18g、盘龙参28g、九里明11g、血藤18g、皱面苦草11g、决明子18g、毛蒌28g、三棱18g。加水提取3次,三次加水量分别相当于药材总重量的12倍、8倍、6倍,每次提取时间分别3小时、2小时、1小时,合并提取液,滤过,滤液浓缩至总重量为药材总重量的3倍,灌装,加入合剂辅料蔗糖、乙酯、水、山梨酸搅拌均匀,制得合剂。
实施例8 口服液
称取扛板归23g、山羊角32g、丁癸草23g、鸡眼草14g、鬼针草23g、夜关门23g、盘龙参32g、九里明14g、血藤23g、皱面苦草14g、决明子23g、毛蒌32g、三棱23g。加水提取2次,两次加水量分别为药材总重量的10倍、8倍,两次提取时间分别为2小时、1小时,合并提取液,滤过,滤液浓缩至80℃时相对密度为1.10的浸膏,在浸膏中加入辅料甘露醇、山梨酸、水搅拌均匀,分装,制得口服液。
实施例9 粉剂
称取扛板归28g、山羊角38g、丁癸草28g、鸡眼草18g、鬼针草28g、夜关门28g、盘龙参38g、九里明18g、血藤28g、皱面苦草18g、决明子28g、毛蒌38g、三棱28g。粉碎,过筛,即得。
临床试验总结
1 一般资料
观察73例流泪症患者,男36例,女37例,年龄40-85岁,病程1个月-6年。
2 治疗方法
给与本发明实施例4治疗,一次4粒,一天3次。30日为一个疗程。
3 疗效评价
治愈:双眼无溢泪现象;
显效:溢泪明显减轻;
无效:溢泪无减轻
4 结果
表1 疗效结果
痊愈 | 显效 | 无效 | 有效率(%) | |
疗效 | 33 | 38 | 2 | 97.3 |
临床结果显示:用本发明对流泪症患者治疗后,有效率达97.3%,表明本发明能有效治疗流泪症。
典型病例
1、李某,女,57岁。双眼反复流泪半年余。患者平素流泪,遇风更甚,伴视物不清,头晕乏力,气短,纳差,双手甲床色泽青紫,舌苔薄白,脉细涩,曾在当地医院检查诊为“功能性溢泪”,并用中西药及泪道冲洗术治疗,效果欠佳。给予本发明实施例7治疗,服药后双眼流泪,头晕乏力,纳差明显好转。继服一周,诸症悉愈,数月后随访未复发。
虽然,上文中已经用一般性说明、具体实施方式及试验,对本发明作了详尽的描述,但在本发明基础上,可以对之作一些修改或改进,这对本领域技术人员而言是显而易见的。因此,在不偏离本发明精神的基础上所做的这些修改或改进,均属于本发明要求保护的范围。
Claims (7)
1.一种治疗流泪症的中药组合物,其特征在于它是由如下重量份的中药原料制备而成的:
扛板归10-30份、山羊角20-40份、丁癸草10-30份、鸡眼草5-20份、鬼针草10-30份、夜关门10-30份、盘龙参20-40份、九里明5-20份、血藤10-30份、皱面苦草5-20份、决明子10-30份、毛蒌20-40份、三棱10-30份。
2.如权利要求1所述的治疗流泪症的中药组合物,其特征在于它是由包括如下重量份的中药原料制备而成的:
扛板归15-25份、山羊角25-35份、丁癸草15-25份、鸡眼草10-15份、鬼针草15-25份、夜关门15-25份、盘龙参25-35份、九里明10-15份、血藤15-25份、皱面苦草10-15份、决明子15-25份、毛蒌25-35份、三棱15-25份。
3.如权利要求1或2所述的治疗流泪症的中药组合物,其特征在于它的活性成分是采用水提或40-80%体积百分浓度的乙醇提取制备而成。
4.如权利要求3所述的治疗流泪症的中药组合物,其特征在于它的活性成分是通过以下方法制备而成的:取全部药材,混合后加水提取2-3次,每次加水量相当于药材总重量的6-12倍,每次提取时间为1-3小时,合并提取液,滤过,滤液浓缩至70-80℃时相对密度为1.15-1.20的清膏,即得活性成分。
5.如权利要求3所述的治疗流泪症的中药组合物,其特征在于它的活性成分是通过以下方法制备而成的:取全部药材,混合后用40-80%乙醇回流提取2-3次,每次乙醇用量为药材总量的4-10倍,提取时间为1-4小时,合并提取液,过滤,滤液浓缩至70-80℃时相对密度为1.15-1.20的清膏,即得活性成分。
6.如权利要求3所述的治疗流泪症的中药组合物,其特征在于它的活性成分是通过以下方法制备而成的:取全部药材,混合后加水提取2-3次,每次加水量相当于药材总重量的6-12倍,每次提取时间为1-3小时,合并提取液,滤过,滤液浓缩至70-80℃时相对密度为1.15-1.20的清膏,加入乙醇,使含醇量为40-70%,静置12-24小时,滤过,滤液浓缩至70-80℃时相对密度为1.10-1.25的浸膏,即得活性成分。
7.一种治疗流泪症的制剂,由权利要求1-6所述的治疗流泪症的中药组合物与医药学上可接受的载体配合制备而成。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201711274803.6A CN107737283A (zh) | 2017-12-06 | 2017-12-06 | 一种治疗流泪症的中药组合物及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201711274803.6A CN107737283A (zh) | 2017-12-06 | 2017-12-06 | 一种治疗流泪症的中药组合物及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN107737283A true CN107737283A (zh) | 2018-02-27 |
Family
ID=61238853
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201711274803.6A Pending CN107737283A (zh) | 2017-12-06 | 2017-12-06 | 一种治疗流泪症的中药组合物及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN107737283A (zh) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20110097425A1 (en) * | 2006-11-02 | 2011-04-28 | Friedlaender Mitchell H | Methods of Treating Epiphora |
CN102600235A (zh) * | 2012-04-09 | 2012-07-25 | 龚建国 | 一种治疗眼病的中药组合滴剂 |
CN106389594A (zh) * | 2016-11-02 | 2017-02-15 | 杨均初 | 一种治疗夜盲症的中药组合物及其制备方法 |
-
2017
- 2017-12-06 CN CN201711274803.6A patent/CN107737283A/zh active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20110097425A1 (en) * | 2006-11-02 | 2011-04-28 | Friedlaender Mitchell H | Methods of Treating Epiphora |
CN102600235A (zh) * | 2012-04-09 | 2012-07-25 | 龚建国 | 一种治疗眼病的中药组合滴剂 |
CN106389594A (zh) * | 2016-11-02 | 2017-02-15 | 杨均初 | 一种治疗夜盲症的中药组合物及其制备方法 |
Non-Patent Citations (1)
Title |
---|
医学教育网: "流泪症-中医辨证论治", 《HTTP://WWW.MED66.COM/NEW/201402/WY201402119919.SHTML?C=61846666》 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105343625A (zh) | 一种排毒除湿利胆的蒲公英口服液及其制备方法 | |
CN103417904B (zh) | 一种治疗慢性唇炎的中药组合物及其制备方法 | |
CN102755596B (zh) | 一种治疗痰湿型乳腺增生的中药及制备方法 | |
CN104666579A (zh) | 一种治疗膝关节滑膜炎的中药组合物及其制备方法 | |
CN104013868A (zh) | 一种治疗慢性阻塞性肺疾病的中药组合物及其制备方法 | |
CN104548008B (zh) | 一种预防和/或治疗过敏性皮肤疾病的药物组合物及其制备方法 | |
CN101485786B (zh) | 一种美白祛斑组合物及其制备方法 | |
CN106215118A (zh) | 抗肿瘤的保健制剂及其制备方法 | |
CN106214997A (zh) | 一种排毒降脂减肥的蒲公英口服液及其制备方法 | |
CN105687788A (zh) | 一种软化血管的药物组合物及其应用 | |
CN104524524B (zh) | 一种治疗骨质疏松的药物及制备方法 | |
CN103623109B (zh) | 一种治疗缺血性脑血管病的中药组合物及其制备方法 | |
CN107737283A (zh) | 一种治疗流泪症的中药组合物及其制备方法 | |
CN106039148A (zh) | 一种保肝蒙药 | |
CN101439150B (zh) | 一种治疗肠炎的中药组合物 | |
CN104721753A (zh) | 一种治疗肝风内动型脑瘤的药物及制备方法 | |
CN104689283A (zh) | 一种治疗脾虚湿蕴型黄褐斑的药物及其制备方法 | |
CN104324139B (zh) | 一种治疗干眼症的药物组合物 | |
CN102940753A (zh) | 一种治疗青光眼的药丸及制备方法 | |
CN105998979A (zh) | 一种治疗肺肾阴虚型慢性咽炎的中药组合物及方法 | |
CN106110204A (zh) | 一种提高免疫力的蒲公英口服液及其制备方法 | |
CN106038451A (zh) | 一种缓解眼袋的中药眼霜及其制备方法 | |
CN105267895A (zh) | 用于治疗牛产后血瘀型胞衣不下的药物及其制备方法 | |
CN105327145A (zh) | 治疗高血压性脑出血的组合物及其制备方法 | |
CN104740478A (zh) | 一种用于急诊处理酒精中毒征的中药丸剂及制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20180227 |
|
WD01 | Invention patent application deemed withdrawn after publication |